| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000042941 |
| Receipt No. | R000049016 |
| Scientific Title | Prospective study on the association between myocardial accumulation and heart disease in FDG PET for tumor diagnosis Myocardial Accumulation and Heart Disease in FDG PET for Tumor Diagnosis |
| Date of disclosure of the study information | 2021/04/01 |
| Last modified on | 2021/02/25 (Ver. 2) |
| Basic information | ||
| Public title | A study to clarify the relationship between FDG PET findings and heart disease for the purpose of tumor diagnosis | |
| Acronym | Association between Tumor FDG PET Findings and Heart Disease | |
| Scientific Title | Prospective study on the association between myocardial accumulation and heart disease in FDG PET for tumor diagnosis
Myocardial Accumulation and Heart Disease in FDG PET for Tumor Diagnosis |
|
| Scientific Title:Acronym | A Prospective Study on the Association between Tumor FDG PET Findings and Heart Disease | |
| Region |
|
|
| Condition | |||
| Condition | Ischemic heart disease. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | There are many overlapping risk factors for carcinogenesis and ischemic heart disease, such as smoking and aging. The purpose of this study was to establish a screening method for heart disease using 18F-fluorodeoxyglucose Positron Emission Tomography (FDG PET), a nuclear medicine test for tumor diagnosis. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To compare myocardial FDG accumulation patterns with the results of cardiac examinations to identify cardiac FDG accumulation patterns that are predictive of heart disease. |
| Key secondary outcomes | Myocardial FDG accumulation is known to be affected by fasting time and diet prior to FDG PET examination, and the optimal pre-test conditions will be discussed. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Myocardial perfusion scintigraphy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Men and women over 60 years old
(2) Scheduled to undergo FDG PET examination as a pre-treatment test for esophageal cancer or lung cancer. (3) Have at least 3 of the following coronary risk factors (male, hypertension(systolic blood pressure >=130 mmHg), type 2 diabetes mellitus, hypertriglyceridemia (TG >=150 mg/dL), hypoHDLemia (HDL<40 mg/dL), smoking history, obesity (BMI>=25)). (4) The contents of this study will be explained in writing and orally, and the subject will understand and give written consent. (5) Good general health (PS2 or less) |
|||
| Key exclusion criteria | (1) History of thoracic surgery or radiation to the chest
(2) Difficult to perform stress myocardial perfusion scintigraphy before treatment for esophageal cancer due to schedule (3) Patients who are not eligible for PET scan or stress myocardial scintigraphy in their regular practice Pregnancy and lactation: Pregnant and lactating women, or those who may be pregnant. History of adverse reaction or allergy related to FDG administration in the past 18F-FDG-PET examination. Prior history of adverse reactions or allergies related to drugs used in myocardial perfusion scintigraphy. Treatment for unstable angina, complete atrioventricular block, or asthma (4) Chest pain suggestive of angina pectoris. (5) Previously indicated coronary artery stenosis of 90% or more by coronary CT and untreated (6) Other conditions considered difficult to participate in the study Difficulty in resting on a bed for 30 minutes Inability to understand the content of the study due to psychosis or psychiatric symptoms Patients who fall into any of the above categories are not eligible for the study. |
|||
| Target sample size | 300 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tohoku University Hospital | ||||||
| Division name | Department of Diagnostic Radiology | ||||||
| Zip code | 980-8574 | ||||||
| Address | Seiryo-cho 1-1, Aoba-ku, Sendai-city | ||||||
| TEL | 022-717-7312 | ||||||
| takanami@rad.med.tohoku.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tohoku University Hospital | ||||||
| Division name | Department of Diagnostic Radiology | ||||||
| Zip code | 980-8574 | ||||||
| Address | Seiryo-cho 1-1, Aoba-ku, Sendai-city | ||||||
| TEL | 022-717-7312 | ||||||
| Homepage URL | |||||||
| mioko.yoshida.b8@tohoku.ac.jp | |||||||
| Sponsor | |
| Institute | Tohoku University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Society for the Promotion of Science |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tohoku University Hospital |
| Address | Seiryo-cho 1-1, Aoba-ku, Sendai City |
| Tel | 022-717-3964 |
| ec@rinri.hosp.tohoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049016 |